These results are relevant to diverse applications: i) HDAC2 as a novel biomarker of the field effect in early colorectal carcinogenesis, ii) the support of HDAC inhibitors and other epigenetic therapies for cancer, and iii) the use of PWS to quantify changes in chromatin architecture of cancer cells. The gene discussed is HDAC9; the disease is cancer.